Brief: Brii Biosciences Says Entered Into License Agreements With VBI Vaccines

VBI Vaccines

06/07/2023 02:39

July 6 (Reuters) - Brii Biosciences Ltd  2137.HK :
    * ENTERED INTO LICENSE AGREEMENTS WITH VBI VACCINES, INC
    * AGREEMENTS TO EXPAND TWO COMPANIES' COLLABORATION IN
HEPATITIS B
VIRUS ("HBV") FIELD
    * UNDER DEAL, CO WILL ACQUIRE FROM VBI EXCLUSIVE GLOBAL
RIGHTS FOR
DEVELOPMENT AND COMMERCIALIZATION OF BRII-179
    * WILL ACQUIRE EXCLUSIVE RIGHTS TO DEVELOP AND COMMERCIALIZE
PREHEVBRI IN GREATER CHINA AND CERTAIN OTHER ASIA PACIFIC
COUNTRIES
    * IN ADDITION, ENTERED INTO A SUPPLY AGREEMENT WITH VBI
WHERE VBI
WILL MANUFACTURE AND SUPPLY BRII-179 TO CO
    * UNDER TERMS VBI WILL BE ENTITLED TO UPFRONT LICENSE FEE OF
US$7
MILLION FOR BRII-179 AND PREHEVBRI
    * WILL MAKE AN ADVANCE PAYMENT OF US$5 MILLION TO VBI UNDER
SUPPLY
AGREEMENT
    * COMPANY WILL MAKE US$3 MILLION EQUITY INVESTMENT IN VBI

Source text for Eikon:  ID: 
Further company coverage:  2137.HK 

 ((Reuters.Briefs@thomsonreuters.com;))